PITTSBURGH, Feb. 5, 2024
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will announce
its fourth quarter and full-year 2023 financial results
Wednesday, Feb. 28, 2024, before the
open of the U.S. financial markets. Chief Executive
Officer Scott A. Smith and
Company executives will host a webcast at 8:30 a.m. ET on the
same date to discuss the results.
Investors and the general public are invited to listen to a live
webcast of the call at investor.viatris.com or by calling
844.308.3344 or 412.317.1896 for international callers. A replay of
the webcast also will be available on the website.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global
healthcare company uniquely positioned to bridge the traditional
divide between generics and brands, combining the best of both to
more holistically address healthcare needs globally. With a mission
to empower people worldwide to live healthier at every stage of
life, we provide access at scale. In 2022 alone, we supplied
high-quality medicines to approximately 1 billion patients around
the world. With our exceptionally extensive and diverse portfolio
of medicines, a one-of-a-kind global supply chain designed to reach
more people when and where they need them, and the scientific
expertise to address some of the world's most enduring health
challenges, access takes on deep meaning at Viatris. We have the
ability to touch all of life's moments, from birth to end of life,
acute conditions to chronic diseases. We are headquartered in the
U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more
at viatris.com and investor.viatris.com, and connect with us
on Twitter
at @ViatrisInc, LinkedIn and YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/viatris-to-announce-fourth-quarter-and-full-year-2023-financial-results-302052745.html
SOURCE Viatris Inc.